Literature DB >> 1771971

Rabies control in the Republic of the Philippines: benefits and costs of elimination.

D B Fishbein1, N J Miranda, P Merrill, R A Camba, M Meltzer, E T Carlos, C F Bautista, P V Sopungco, L C Mangahas, L M Hernandez.   

Abstract

We compared the benefits and costs of eliminating animal and human rabies in the Philippines. If rabies had been eliminated in 1988, economic benefits would total P52.8 (US$2.5) million in 1989. These benefits would largely arise from the abolition of expenses associated with rabies prevention: P29.7 (US$1.4) million for animal vaccination, P21.6 (US$1.0) million for human postexposure prophylaxis, and P0.3 (US$0.02) million for animal rabies examinations. Benefits also included P1.2 (US$0.06) million in additional earnings of humans whose death due to rabies would be prevented. Nationwide elimination was estimated to cost between P88.1 (US$4.2) million and P317.2 (US$15.0) million, assuming a canine-to-human ratio of 1:10, vaccine coverage of 60%, and a cost per vaccination of no less than P25 (US$1.19) and no more than P90 (US$4.27). These costs would be recouped 4.1-11.0 years after the initiation of a one-year elimination campaign. A sensitivity analysis showed that an elimination programme would be economically beneficial in all but the most extreme cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1771971     DOI: 10.1016/0264-410x(91)90246-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

Review 1.  A review of the economics of the prevention and control of rabies. Part 2: Rabies in dogs, livestock and wildlife.

Authors:  M I Meltzer; C E Rupprecht
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

Review 2.  A review of the economics of the prevention and control of rabies. Part 1: Global impact and rabies in humans.

Authors:  M I Meltzer; C E Rupprecht
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

3.  The feasibility of canine rabies elimination in Africa: dispelling doubts with data.

Authors:  Tiziana Lembo; Katie Hampson; Magai T Kaare; Eblate Ernest; Darryn Knobel; Rudovick R Kazwala; Daniel T Haydon; Sarah Cleaveland
Journal:  PLoS Negl Trop Dis       Date:  2010-02-23

4.  Imported episodic rabies increases patient demand for and physician delivery of antirabies prophylaxis.

Authors:  Zélie Lardon; Laurence Watier; Audrey Brunet; Claire Bernède; Maryvonne Goudal; Laurent Dacheux; Yolande Rotivel; Didier Guillemot; Hervé Bourhy
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

5.  Factors associated with dog rabies vaccination in Bhol, Philippines: results of a cross-sectional cluster survey conducted following the island-wide rabies elimination campaign.

Authors:  S Davlin; S M Lapiz; M E Miranda; K Murray
Journal:  Zoonoses Public Health       Date:  2012-12-28       Impact factor: 2.702

Review 6.  Rabies in China: recommendations for control.

Authors:  A Kureishi; L Z Xu; H Wu; H G Stiver
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

7.  Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination.

Authors:  M Kaare; T Lembo; K Hampson; E Ernest; A Estes; C Mentzel; S Cleaveland
Journal:  Vaccine       Date:  2008-10-09       Impact factor: 3.641

8.  Implementation of an intersectoral program to eliminate human and canine rabies: the Bohol Rabies Prevention and Elimination Project.

Authors:  Stella Marie D Lapiz; Mary Elizabeth G Miranda; Romulo G Garcia; Leonida I Daguro; Meydalyn D Paman; Frederick P Madrinan; Polizena A Rances; Deborah J Briggs
Journal:  PLoS Negl Trop Dis       Date:  2012-12-06

9.  Costs of rabies control: an economic calculation method applied to Flores Island.

Authors:  Ewaldus Wera; Annet G J Velthuis; Maria Geong; Henk Hogeveen
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

10.  Willingness to Pay for Dog Rabies Vaccine and Registration in Ilocos Norte, Philippines (2012).

Authors:  Meseret G Birhane; Mary Elizabeth G Miranda; Jessie L Dyer; Jesse D Blanton; Sergio Recuenco
Journal:  PLoS Negl Trop Dis       Date:  2016-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.